dual glp 1 and gip receptor agonist examples Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research The current significance and prospects

Glucose-dependent insulinotropic polypeptide suppresses foam cell formation of macrophages through inhibition of the cyclin-dependent kinase 5CD36 pathway

You can register for free for limited further access, or subscribe now for full access to all our content

We completed a 12-week, randomized, double-blind, placebo-controlled Phase 2 clinical trial of NG101, in which we enrolled patients with moderate to severe idiopathic or diabetic gastroparesis

Therefore, DPP-4 inhibitors, like GLP-1R agonists, may be a potential drug for the treatment of AD

7% in the triple therapy arm ( p = 0.04)

The inhibitory effects of peripheral administration of peptide YY 3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway